Testing effectiveness (Phase 2)Ended earlyNCT02597153
What this trial is testing
Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas
Who this might be right for
Relapsed Cutaneous T Cell Lymphom
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 1